Print Page   |   Contact Us   |   Sign In   |   Register
Board of Directors

The Board of Directors is the ultimate governing authority of the Sarnoff Cardiovascular Research Foundation. Its mission is to govern the Foundation, protect the organization's image and assets, and be the moral voice of the Sarnoff community.

The Articles of Incorporation and Bylaws of the foundation require that a majority of seats on its Board of Directors shall be persons nominated by the foundation's designated medical institutions ("Publicly Supported Organizations," defined in the Internal Revenue Code). Dr. Sarnoff's successor nominates candidates for the remaining positions on the Board. Elected members who were nominated by the PSOs shall always constitute a majority of the Board. Director vacancies are filled on an annual basis; the Directors serve staggered terms. The present Board consists of fifteen voting members. The Executive Director serves as a non-voting member. 

The Board of Directors of the Sarnoff Cardiovascular Research Foundation, a 501(c)(3) public charity, is required to be controlled by Directors who are nominated to the Board by Publicly Supported organizations (PSOs), as that term is defined in the Internal Revenue Code. PSOs must be actively engaged in developing, encouraging and maintaining a cardiovascular science program in the United States. The ten nominating PSOs of the Foundation are: Columbia University, Duke University, Johns Hopkins University, Mount Sinai Medical Center, Northwestern University, University at Buffalo, University of Iowa, University of Texas Southwestern Medical Center, University of Washington and Vanderbilt University. These ten PSOs are thus entitled to nominate candidates for election to the Board of Directors. The Permanent Successor to Dr. Stanley J. Sarnoff nominates the remaining candidates for election to the Board of Directors. The current Permanent Successor to Dr. Stanley J. Sarnoff is Dr. Jon Lomansey.

 

 

 

Joseph Hill, MD, PhD 
Chair


Dr. Hill is Professor Internal Medicine and Molecular Biology, Chief of Cardiology at the UT Southwestern Medical Center and Director of the Harry S. Moss Heart Center. He was graduated from Duke University with MD and PhD degrees in 1987. Dr. Hill is the Chair of the Development Committee, and former member of the Scientific Committee. 

Term Ends: 2020.

 

 

Ronglih Liao, PhD

Vice Chair

 

Dr. Liao a Professor of Medicine at Harvard Medical School. She also directs the Cardiovascular Physiology and FACS Cores at Brigham and Women's Hospital. Dr. Liao received her PhD from the University of Alabama, Birmingham. She is a former member of the Scientific Committee. 

Term Ends:  2020.


Daniel Garry, MD, PhD
Immediate Past Chair


Dr. Garry is the St. Jude Medical Endowed Chair in Cardiology, Director, Lillehei Heart Institute and Chief, Cardiovascular Division, Department of Medicine at the University of Minnesota. He received his MD and PhD from the University of Minnesota and pursued postdoctoral training at UT Southwestern Medical Center at Dallas. He is a former Chair of the Scientific Committee.

Term Ends: 2020.

 



 

Ricardo Guerra, MD 

Treasurer

Dr. Rich Guerra is Cardiologist at North Texas Heart Center and currently serves as the Chief of Cardiology for the Medical Center of McKinney.  He received his medical degree at the University of California, San Francisco.  Dr. Guerra is a former Sarnoff Fellow and Scholar. 

Term Ends: 2020.


 
 

 

Javid Moslehi, MD
Secretary

 

Dr. Moslehi is Assistant Professor of Medicine and Director, Cardio-Oncology Program at Vanderbilt University School of Medicine. He received his medical degree from the University of Connecticut School of Medicine. Dr. Moslehi is a former Sarnoff fellow.

Term ends:  2020.

 

 

Michelle Albert, MD

Dr. Albert is Professor in Medicine at the University of California at San Francisco (UCSF) ad director of the CeNter for the StUdy of AdverRsiTy and CardiovascUlaR DiseasE (NURTURE Research Center). Dr. Albert is a graduate of the University of Rochester School of Medicine. 

Term ends: 2021.


 
 

Charles Hong, MD, PhD

Dr. Hong is Director of Research, Associate Chief of Cardiology ad Melvin Sharoky Chair at the University of Maryland School of Medicine.  He received his MD and PhD from Yale University.  Dr. Hong is a former Sarnoff Fellow and Scholar and the current Chair of the Scientific Committee.

Term ends:  2020.

 

 

Richard Kitsis, MD

Dr. Kitsis is the Dr. Gerald and Myra Dorros Chair in Cardiovascular Disease and Director, Wilf Family Cardiovascular Research Institute at Albert Einstein College of Medicine.  Dr. Kitsis received his MD from the University of California, San Francisco. Dr. Kitsis is a former Chair of the Scientific Committee.

Term Ends:  2022.

 

 

Daniel Levy, MD

Dr. Levy is the Director of the Framingham Heart Study - National Heart Lung and Blood Institute (NIH). He received his M.D. from the Boston University School of Medicine.  Dr. Levy is a former Preceptor and former Chair of the Scientific Committee.
Term ends:  2021.

 

 

Jon Lomasney, MD

Permanent Successor

Dr. Lomasney is Associate Professor, Department of Pathology and Department of Molecular Pharmacology and Biological Chemistry and Director of the Feinberg Academy of Medical Educators at Northwestern University Medical School. He received his medical degree from Dartmouth and completed his residency at Johns Hopkins. He was a Sarnoff Fellow and Sarnoff Scholar at Duke University Medical Center. He served on the Scientific Committee from 
1993-96.
Term Ends: N/A. Permanent successor to Dr. Stanley J. Sarnoff.

 

 
 

Thomas Michel, MD, PhD

 

Dr. Michel is Professor of Medicine and Biochemistry at Harvard Medical School, Senior Physician in Cardiovascular Medicine at Brigham and Women's Hospital, and Associate Director of the Harvard-MIT MD/PhD Program.  He holds an MD and PhD from Duke University.  Dr. Michel is a former Chair of the Scientific Committee.
Term ends:  2021.

 

 

Rosanne Rouf, MD

 

Dr. Rouf is Director, Heart Failure Program and Assistant Professor of Medicine at Johns Hopkins University School of Medicine.  She received her MD from Duke University.  Dr. Rouf is a former Sarnoff Fellow and Scholar and the current Chair of the Alumni Committee. 
Term ends:  2020.

 

Membership Management Software Powered by YourMembership  ::  Legal